Andrew D. Ashe

Companies

• Verve Therapeutics, Inc.Officer Jun 16, 2021 to now¹
• Applied Genetic Technologies CorporationGeneral counsel Aug 3, 2017 to Aug 3, 2017²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• VTVerve Therapeutics, Inc.0 shares³Jul 25, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 25, 2025U 348,828 shares of Verve Therapeutics, Inc.³
• Apr 2, 2025Sold 2,681 shares at $4.15 of Verve Therapeutics, Inc.⁴
• Apr 1, 2025Exercised options 9,000 shares of Verve Therapeutics, Inc.⁴
• May 14, 2024Bought 76,000 shares at $6.26 of Verve Therapeutics, Inc.⁵
• Aug 25, 2022Exercised options 10,835 shares at $2.87 of Verve Therapeutics, Inc.⁶
• Aug 25, 2022Exercised options 33,749 shares at $1.48 of Verve Therapeutics, Inc.⁶
• Aug 25, 2022Exercised options 51,203 shares at $1.39 of Verve Therapeutics, Inc.⁶
• Dec 2, 2021Bought 4,000 shares at $32.10 of Verve Therapeutics, Inc.⁷